Warning letter
Bayer Corporation Consumer Care Division: warning letter of Jul 20, 2000
FDA warning letter UCM068629 · Philadelphia District Office
Key facts
| Reference number | UCM068629 |
|---|---|
| Company | Bayer Corporation Consumer Care Division |
| Subject | Cipor HC Otic/Current Good Manufacturing Practices/Laboratory Controls |
| Issue date | Jul 20, 2000 |
| Posted date | Jul 20, 2000 |
| Issuing office | Philadelphia District Office |
| Product type | Drugs |
| CFR sections cited | 211, 211.192 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: